Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109317734 | 10931773 | 4 | F | 20160723 | 20160727 | 20150319 | 20160803 | EXP | PHHY2015AU027688 | NOVARTIS | 82.11 | YR | M | Y | 0.00000 | 20160803 | CN | COUNTRY NOT SPECIFIED | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109317734 | 10931773 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG | U | S0287,S0046,347407, 349238,350145 | 21008 | 40 | MG | SUSPENSION | |||||
| 109317734 | 10931773 | 2 | C | WARFARIN | WARFARIN | 1 | Unknown | U | 0 | ||||||||||
| 109317734 | 10931773 | 3 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 25 MG | U | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109317734 | 10931773 | 1 | Carcinoid syndrome |
| 109317734 | 10931773 | 2 | International normalised ratio abnormal |
| 109317734 | 10931773 | 3 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109317734 | 10931773 | OT |
| 109317734 | 10931773 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109317734 | 10931773 | Blood glucose increased | |
| 109317734 | 10931773 | Body temperature increased | |
| 109317734 | 10931773 | Impaired healing | |
| 109317734 | 10931773 | Infected skin ulcer | |
| 109317734 | 10931773 | Malaise | |
| 109317734 | 10931773 | Second primary malignancy | |
| 109317734 | 10931773 | Skin cancer | |
| 109317734 | 10931773 | Skin ulcer | |
| 109317734 | 10931773 | Urinary bladder haemorrhage | |
| 109317734 | 10931773 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |